newsfilter
← Latest News
Business Wire·

Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020 and reviewed recent business progress.